Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
28.97
+0.86 (3.06%)
At close: Aug 13, 2025, 4:00 PM
28.97
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:29 AM EDT
Ultragenyx Pharmaceutical Employees
Ultragenyx Pharmaceutical had 1,294 employees as of December 31, 2024. The number of employees increased by 18 or 1.41% compared to the previous year.
Employees
1,294
Change (1Y)
18
Growth (1Y)
1.41%
Revenue / Employee
$471,529
Profits / Employee
-$411,849
Market Cap
2.79B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RARE News
- 8 days ago - Ultragenyx Pharmaceutical Inc. (RARE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Ultragenyx Reports Second Quarter 2025 Financial Results and Corporate Update - GlobeNewsWire
- 15 days ago - Ultragenyx to Host Conference Call for Second Quarter 2025 Financial Results and Corporate Update - GlobeNewsWire
- 16 days ago - Ultragenyx: July Selloff Creates Buying Opportunity Ahead Of UX143 Catalyst - Seeking Alpha
- 16 days ago - Ultragenyx Represents 'Intriguing Buying Opportunity,' Despite Recent Setbacks - Benzinga
- 26 days ago - Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 26 days ago - RARE Investors Have Opportunity to Join Ultragenyx Pharmaceutical Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 4 weeks ago - Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga